A side effect of therapy with procainamide and numerous other medications is a lupus-like syndrome characterized by autoantibodies directed against denatured DNA and the (H2A-H2B)-DNA subunit of chromatin. We tested the possibility that an effect of lupus-inducing drugs on central T cell tolerance underlies these phenomena. Two intrathymic injections of procainamide-hydroxylamine (PAHA), a reactive metabolite of procainamide, resulted in prompt production of IgM antidenatured DNA antibodies in C57BL/6xDBA/2 F1 mice. Subsequently, IgG antichromatin antibodies began to appear in the serum 3 wk after the second injection and were sustained for several months. Specificity, inhibition and blocking studies demonstrated that the PAHA-induced antibodies showed remarkable specificity to the (H2A-H2B)-DNA complex. No evidence for polyclonal B cell activation could be detected based on enumeration of Ig-secreting B cells and serum Ig levels, suggesting that a clonally restricted autoimmune response was induced by intrathymic PAHA. The IgG isotype of the antichromatin antibodies indicated involvement of T cell help, and proliferative responses of splenocytes to oligonucleosomes increased up to 100-fold. As little as 5 microM PAHA led to a 10-fold T cell proliferative response to chromatin in short term organ culture of neonatal thymi. We suggest that PAHA interferes with self-tolerance mechanisms accompanying T cell maturation in the thymus, resulting in the emergence of chromatin-reactive T cells followed by humoral autoimmunity.
A Kretz-Rommel, S R Duncan, R L Rubin
Title and authors | Publication | Year |
---|---|---|
Autoreactive B cells recruited to lungs by silica exposure contribute to local autoantibody production in autoimmune-prone BXSB and B cell receptor transgenic mice.
Fee L, Kumar A, Tighe RM, Foster MH |
Frontiers in immunology | 2022 |
Machine Learning for Predicting Risk of Drug-Induced Autoimmune Diseases by Structural Alerts and Daily Dose
Y Wu, J Zhu, P Fu, W Tong, H Hong, M Chen |
International journal of environmental research and public health | 2021 |
Cutaneous drug-induced lupus erythematosus: Clinical and immunological characteristics and update on new associated drugs
P Bataille, F Chasset, JB Monfort, TD Risi-Pugliese, A Soria, C Francès, A Barbaud, P Senet |
Annales de Dermatologie et de Vénéréologie | 2021 |
Mechanistic Insights of Chemicals and Drugs as Risk Factors for Systemic Lupus Erythematosus
Q Pan, Y Guo, L Guo, S Liao, C Zhao, S Wang, HF Liu |
Current medicinal chemistry | 2020 |
Cutaneous drug eruptions including serum sickness-like reaction, symmetrical drug-related intertriginous and flexural exanthema, and drug-induced lupus
K McNamara, OB Hughes, LC Strowd |
Clinics in Dermatology | 2020 |
Drug-induced lupus: Traditional and new concepts
A Vaglio, PC Grayson, P Fenaroli, D Gianfreda, V Boccaletti, GM Ghiggeri, G Moroni |
Autoimmunity Reviews | 2018 |
Drug-induced lupus erythematosus: an update on drugs and mechanisms
Y He, AH Sawalha |
Current Opinion in Rheumatology | 2018 |
Lupus
WA Khan |
Lupus | 2017 |
Procainamide-induced autoimmunity: Relationship to T-helper 2-type T-cell activation
Y Huang, Z Lin, Y Huo, X Geng, M Li, Y Yang, B Li |
Human & Experimental Toxicology | 2017 |
Drug-induced lupus
RL Rubin |
Expert Opinion on Drug Safety | 2015 |
Drug-induced lupus: Including anti-tumour necrosis factor and interferon induced
S Araújo-Fernández, M Ahijón-Lana, DA Isenberg |
Lupus | 2014 |
Dubois' Lupus Erythematosus and Related Syndromes
JC Crispín, GC Tsokos |
Dubois' Lupus Erythematosus and Related Syndromes | 2013 |
Lupus érythémateux
P Dieudé, E Lazaro, C Richez |
Lupus érythémateux | 2013 |
Idiosyncratic Drug Reactions
ZW Wojcinski, JP Uetrecht |
Encyclopedia of Drug Metabolism and Interactions | 2012 |
Lupus eritematoso inducido por fármacos
M Pretel, L Marquès, A España |
Actas Dermo-Sifiliográficas | 2012 |
Drug-Induced Lupus Mechanisms
RL Yung, BC Richardson |
Systemic Lupus Erythematosus | 2011 |
Drug-Induced Lupus Erythematosus: Incidence, Management and Prevention
C Chang, ME Gershwin |
Drug Safety | 2011 |
Drugs and autoimmunity – A contemporary review and mechanistic approach
C Chang, ME Gershwin |
Journal of Autoimmunity | 2010 |
Application of the modified vaccination technique for the prevention and cure of chronic ailments
AZ Barabas, CD Cole, AD Barabas, RM Graeff, R Lafreniere, DM Weir |
Asian Pacific Journal of Tropical Medicine | 2010 |
Comprehensive Toxicology
JM Sands, JW Verlander |
Comprehensive Toxicology | 2010 |
Adverse Drug Reactions
J Uetrecht |
2009 | |
Adverse Drug Reactions
J Uetrecht |
2009 | |
Adverse Drug Reactions
J Uetrecht |
2009 | |
Adverse Drug Reactions
J Uetrecht |
2009 | |
Adverse Drug Reactions
J Uetrecht |
2009 | |
Adverse Drug Reactions
J Uetrecht |
2009 | |
Adverse Drug Reactions
J Uetrecht |
2009 | |
Adverse Drug Reactions
J Uetrecht |
2009 | |
Adverse Drug Reactions
J Uetrecht |
2009 | |
Adverse Drug Reactions
J Uetrecht |
2009 | |
Drug-induced lupus: an update on its dermatologic aspects
AV Marzano, P Vezzoli, C Crosti |
Lupus | 2009 |
Pay close attention to drug-induced lupus
MJ Zhou |
Journal of Chinese Integrative Medicine | 2008 |
Clinical Nephrotoxins
ME Broe, GA Porter, WM Bennett, G Deray |
2008 | |
A female preponderance for chemically induced lupus in SJL/J mice
DL Smith, X Dong, S Du, M Oh, RR Singh, RR Voskuhl |
Clinical Immunology | 2007 |
Drug-Induced Lupus
AT Borchers, CL Keen, ME Gershwin |
Annals of the New York Academy of Sciences | 2007 |
Regulatory T Cells in Lupus
HK Kang, SK Datta |
International Reviews of Immunology | 2006 |
Systemic Lupus Erythematosus
M Petri |
JCR: Journal of Clinical Rheumatology | 2006 |
Advances in Molecular Toxicology
JP Uetrecht |
Advances in Molecular Toxicology | 2006 |
Drug-induced lupus: an update
S Vasoo |
Lupus | 2006 |
Principles of Molecular Medicine
MS Runge, C Patterson |
2006 | |
Quinidine and procainamide inhibit murine macrophage uptake of apoptotic and necrotic cells: A novel contributing mechanism of drug-induced-lupus
J Ablin, I Verbovetski, U Trahtemberg, S Metzger, D Mevorach |
Apoptosis | 2005 |
Drug-induced lupus
RL Rubin |
Toxicology | 2005 |
Current trends in drug-induced autoimmunity
J Uetrecht |
Autoimmunity Reviews | 2005 |
RETRACTED: Drug-induced lupus erythematosus
P Sarzi-Puttini, F Atzeni, P Sarzi-Puttini, F Atzeni, F Capsoni, P Sarzi-Puttini, F Atzeni, F Capsoni, E Lubrano, P Sarzi-Puttini, F Atzeni, F Capsoni, E Lubrano, A Doria, P Sarzi-Puttini, F Atzeni, F Capsoni, E Lubrano, A Doria |
Autoimmunity | 2005 |
Cutaneous Lupus Erythematosus
A Kuhn, P Lehmann, T Ruzicka |
2005 | |
Drug-induced lupus erythematosus
D Antonov, J Kazandjieva, D Etugov, D Gospodinov, N Tsankov |
Clinics in Dermatology | 2004 |
Animal models of idiosyncratic drug reactions
JM Shenton, J Chen, JP Uetrecht |
Chemico-Biological Interactions | 2004 |
Hydralazine may induce autoimmunity by inhibiting extracellular signal-regulated kinase pathway signaling
C Deng, Q Lu, Z Zhang, T Rao, J Attwood, R Yung, B Richardson |
Arthritis & Rheumatism | 2003 |
Major Peptide Autoepitopes for Nucleosome-Centered T and B Cell Interaction in Human and Murine Lupus
SK Datta |
Annals of the New York Academy of Sciences | 2003 |
Drug-induced autoimmunity:
WJ Pichler |
Current Opinion in Allergy and Clinical Immunology | 2003 |
Influence of MHC CLASS II in Susceptibility to Beryllium Sensitization and Chronic Beryllium Disease
LA Maier, DS McGrath, H Sato, P Lympany, K Welsh, R du Bois, L Silveira, AP Fontenot, RT Sawyer, E Wilcox, LS Newman |
Journal of immunology (Baltimore, Md. : 1950) | 2003 |
Les lupus induits par les médicaments
J Sibilia |
Revue du Rhumatisme | 2002 |
Phagocyte-mediated oxidation in idiosyncratic adverse drug reactions
RL Rubin, A Kretz-Rommel |
Current Opinion in Hematology | 2001 |
Early Cellular Events in Systemic Autoimmunity Driven by Chromatin-Reactive T Cells
A Kretz-Rommel, RL Rubin |
Cellular Immunology | 2001 |
Phagocyte-mediated oxidation in idiosyncratic adverse drug reactions:
RL Rubin, A Kretz-Rommel |
Current Opinion in Hematology | 2001 |
Thymus Function in Drug-Induced Lupus
RL Rubin, DR Salomon, RS Guerrero |
Lupus | 2001 |
Animal models of autoimmunity and their relevance to human diseases
S Sakaguchi |
Current Opinion in Immunology | 2000 |
Genetic dissection of lupus pathogenesis: a recipe for nephrophilic autoantibodies
C Mohan, L Morel, P Yang, H Watanabe, B Croker, G Gilkeson, EK Wakeland |
Journal of Clinical Investigation | 1999 |
Autoreactive T cells in murine lupus
J Craft, S Peng, T Fujii, M Okada, S Fatenejad |
Immunologic Research | 1999 |
Etiology and mechanisms of drug-induced lupus
RL Rubin |
Current Opinion in Rheumatology | 1999 |
Initiation of autoimmunity by a reactive metabolite of a lupus-inducing drug in the thymus
RL Rubin, A Kretz-Rommel |
Environmental Health Perspectives | 1999 |
Environmentally induced autoimmune diseases: potential mechanisms
T Rao, B Richardson |
Environmental Health Perspectives | 1999 |
Autoreactive T cells in murine lupus: Origins and Roles in Autoantibody Production
J Craft, S Peng, T Fujii, M Okada, S Fatenejad |
Immunologic Research | 1999 |
Procainamide, a Drug Causing Lupus, Induces Prostaglandin H Synthase-2 and Formation of T Cell-Sensitizing Drug Metabolites in Mouse Macrophages
C Goebel, C Vogel, M Wulferink, S Mittmann, B Sachs, S Schraa, J Abel, G Degen, J Uetrecht, E Gleichmann |
Chemical Research in Toxicology | 1999 |
B-cell epitope spreading in autoimmunity
JA James, JB Harley |
Immunological Reviews | 1998 |
Drug-Induced Lupus Erythematosus
KD PhD |
Clinics in Dermatology | 1998 |
Production of pathogenic antibodies: Cognate interactions between autoimmune T and B cells
SK Datta |
Lupus | 1998 |
Induction of colitis in IL2-deficient-mice: the role of thymic and peripheral dysregulation in the generation of autoreactive T cells
RO Ehrhardt, B Ludviksson |
Research in Immunology | 1997 |
The Clinical Utility of Antihistone Antibodies
RW Burlingame |
Clinics in Laboratory Medicine | 1997 |
Advances in Pharmacology
B Drenger, Y Ginosar, Y Gozal |
Advances in Pharmacology | 1994 |